Stay updated on APR-246 & Azacitidine in TP53 MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.

Latest updates to the APR-246 & Azacitidine in TP53 MDS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedVersion 2025-03-06 shows updates to the Study Status and Contacts/Locations sections in the record history, indicating changes to the trial's current status. The updated entries reflect the latest status and contact information for the study.SummaryDifference0.1%

- Check42 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference11%

- Check49 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

- Check63 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; no substantive content changes; 'Back to Top' link removed.SummaryDifference0.7%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

- Check77 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference25%

Stay in the know with updates to APR-246 & Azacitidine in TP53 MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246 & Azacitidine in TP53 MDS Clinical Trial page.